SCHEMBL16626517

SCHEMBL16626517

CNCc1cn(S(=O)(=O)c2cccc(OC(F)(F)F)c2)c2cc(Nc3ccc(OC(F)(F)F)cc3C)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 6/20 0.39
FBP1 P09467 2/20 0.38
P2RX7 Q99572 6/20 0.37
FGFR4 P22455 1/20 0.37
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
RORC P51449 2/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
PTGES2 Q9H7Z7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618699 0.99 HTR6 (0.39) HTR6FBP1P2RX7FGFR4PPARG
SCHEMBL17971562 0.97 FBP1 (0.43) HTR6FBP1P2RX7PPARGPPARD
SCHEMBL16626491 0.97 FBP1 (0.43) HTR6FBP1P2RX7PPARGPPARD
Hydrochloric Acid SCHEMBL16618832 0.96 FBP1 (0.42) HTR6FBP1P2RX7PPARGPPARD
SCHEMBL16626741 0.95 RORC (0.42) HTR6FBP1P2RX7FGFR4PPARG
Hydrochloric Acid SCHEMBL16618714 0.95 RORC (0.42) HTR6FBP1P2RX7FGFR4PPARG
SCHEMBL17975820 0.94 RORC (0.42) HTR6P2RX7PPARGPPARDPPARA
SCHEMBL16626470 0.94 HTR6 (0.39) HTR6P2RX7PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL16618543 0.94 HTR6 (0.39) HTR6P2RX7PPARGPPARDPPARA
Hydrochloric Acid SCHEMBL16619295 0.94 RORC (0.42) HTR6P2RX7PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885FBP1 74/4885P2RX7 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.